Department of Health and Human Services
National Institutes of Health
Toggle navigation
Search
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
How to Search
Contact Us
Search the Studies
Go Back
Searched Result
61 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Please note that only the first 5 legal search words are being processed.
Protocol Number
Title
Protocol Status
Min-Max Age
Institute
Keywords
001690-DK
Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate
Participants currently recruited/enrolled
18-65 Years
NIDDK
Mass Index
000235-CH
COLSIO Trial: Phase II Randomized, Controlled Trial of Colchicine to Suppress Inflammation and Improve Insulin Resistance in Adults and Adolescents with Obesity
Participants currently recruited/enrolled
12-100 Years
NICHD
Mass Index
000220-DK
Phase II Trial of the Combination of Alpha-lipoic Acid and Mirabegron in Women and in Men with Obesity
Recruitment has not started
18-65 Years
NIDDK
Mass Index
22-DK-0002
Effect of Ultra-processed versus Unprocessed Diets on Energy Metabolism
Participants currently recruited/enrolled
18-60 Years
NIDDK
Mass Index
20-H-0044
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis
Completed Study; data analyses ongoing
18-80 Years
NHLBI
Mass Index
19-CH-0051
Long-Term Follow-UP of Survivors of Pediatric Cushing Disease
Participants currently recruited/enrolled
2-90 Years
NICHD
Mass Index
18-H-0019
Effect of Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
Participants currently recruited/enrolled
18-99 Years
NHLBI
Mass Index
18-D-0114
An Open Label Pilot Study of Denosumab Treatment for Fibrous Dysplasia
No longer recruiting/follow-up only
18-125 Years
NIDCR
Index Quantitative
18-AA-0047
Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
Clinical hold/Recruitment or enrollment suspended
18-60 Years
NIAAA
Mass Index
17-DK-0054
The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment with Beta3-Adrenergic Receptor Agonists
Participants currently recruited/enrolled
18-40 Years
NIDDK
Mass Index
17-CH-0014
Pilot Study of Mobile Attention Training in Overweight Female Adolescents
Participants currently recruited/enrolled
12-21 Years
NICHD
Mass Index
16-H-0085
Pilot Study to Evaluate the Effect of Fasting and Refeeding on T-Cell Fate
Completed Study; data analyses ongoing
21-37 Years
NHLBI
Mass Index
15-AG-0063
The Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)
Participants currently recruited/enrolled
20-125 Years
NIA
Mass Index
14-CC-0143
Sleep Disturbance and Relapse in Individuals with Alcohol Dependence: An Exploratory Mixed Methods Study
Completed Study; data analyses ongoing
18-125 Years
CC
Index Quantitative
13-HG-0158
Patient Perspectives and Simulated Clinical Interactions
Completed Study; data analyses ongoing
18-50 Years
NHGRI
Mass Index
11-CC-0120
Stereophotogrammetry of the Torso in Healthy Individuals and Patients with Scoliosis, Chest Wall Deformations, or Obesity
Completed Study; data analyses ongoing
2-125 Years
CC
Mass Index
09-DK-0097
Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women
Completed Study; data analyses ongoing
18-55 Years
NIDDK
Mass Index
08-DK-N191
The Effects of Transcranial Direct Current Stimulation (TDCS) on Food Intake and Weight Loss
Participants currently recruited/enrolled
18-60 Years
NIDDK
Mass Index
08-DK-N140
Predicting Adaptive Thermogenesis
Completed Study; data analyses ongoing
18-60 Years
NIDDK
Mass Index
05-CH-0037
The Effects of Hydrocortisone, Melatonin, and Placebo on Symptoms of Jet Lag
Completed Study; data analyses ongoing
18-65 Years
NICHD
Mass Index
01-DK-N117
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Participants currently recruited/enrolled
18-99 Years
NIDDK
Index Trait
99-DK-0002
Diabetes and Heart Disease Risk in Blacks
Participants currently recruited/enrolled
18-70 Years
NIDDK
Mass Index
96-CH-0033
An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children with Congenital Adrenal Hyperplasia
No longer recruiting/follow-up only
2-18 Years
NICHD
Mass Index
001621-H
Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting with Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
Recruitment has not started
18-120 Years
NHLBI
Mass
001546-DA
Spironolactone in Alcohol Use Disorder (SAUD): A Double-Blind, Placebo-Controlled, Ascending Dose, Phase 1b Study
Participants currently recruited/enrolled
21-99 Years
NIDA
Mass
001505-N
A Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, First In-Patient Study of AJ201 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Adults With Spinal and Bulbar Muscular Atrophy (SBMA)
Participants currently recruited/enrolled
18-120 Years
NINDS
Mass
001074-CH
Characterization of Dysmorphology in Subjects with Creatine Transporter Deficiency
Participants currently recruited/enrolled
2-40 Years
NICHD
Trait
000906-I
A Phase 2 Randomized Cross-Over Design Study of the Early Metabolic Effects of Dolutegravir or Tenofovir Alafenamide in Healthy Volunteers
Participants currently recruited/enrolled
18-55 Years
NIAID
Mass
000784-N
Assessing and Improving Quantitative Magnetic Resonance Imaging Metrics in Human Subjects
Participants currently recruited/enrolled
18-125 Years
NINDS
Quantitative
000748-DK
Analysis of the Utility of Polygenic Scores for Prediction of Incident Type 2 Diabetes Across Multiple Ancestry Groups
No longer recruiting/follow-up only
0-125 Years
NIDDK
Index
000682-AR
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients with Systemic Lupus Erythematosus
Participants currently recruited/enrolled
18-80 Years
NIAMS
Index
000428-N
An Observational Study to Assess Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
Participants currently recruited/enrolled
18-120 Years
NINDS
Mass
000417-CC
Characterization of the Nociception Phenotype in Individuals with Intellectual Disability
Participants currently recruited/enrolled
8-30 Years
CC
Quantitative
000411-CC
A Feasibility Pilot Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adults with Congenital Adrenal Hyperplasia.
Participants currently recruited/enrolled
16-22 Years
CC
Index
000237-C
Phase II Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis from Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
Index
000051-N
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
Participants currently recruited/enrolled
48-70 Years
NINDS
Mass
000037-CC
Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis from Existing Radiologic Images
No longer recruiting/follow-up only
0-125 Years
CC
Mass
20-N-0064
An observational study to assess clinical manifestations and biomarkers in amyotrophic lateral sclerosis type 4 and other inherited neurological disorders of RNA processing.
Participants currently recruited/enrolled
5-120 Years
NINDS
Mass
20-H-0080
Red Cell Half Life Determination in Patients with and without Sickle Cell Disease
Completed Study; data analyses ongoing
18-99 Years
NHLBI
Trait
20-H-0068
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
Participants currently recruited/enrolled
18-80 Years
NHLBI
Trait
19-AT-0089
Sensory Afferents for Deep Pressure Sensation
Completed Study; data analyses ongoing
18-50 Years
NCCIH
Mass
18-HG-0129
Reverse Phenotyping Core (RPC)
Enrolling by Invitation
4-120 Years
NHGRI
Trait
18-H-0146
Genotype -Phenotype Correlation of PKLR Variants with Pyruvate Kinase, 2,3-Diphosphglycerate and ATP Activities in Red Blood Cells of Patients with Sickle Cell Disease
Participants currently recruited/enrolled
18-80 Years
NHLBI
Trait
17-C-0048
Anti-CD30 CAR T Cells with Fully-human Binding Domains for Treating CD30-expressing Lymphomas Including Anaplastic Large Cell Lymphomas
Completed Study; data analyses ongoing
18-73 Years
NCI
Mass
16-I-0065
Screening for Alpha Globin Deletions
Participants currently recruited/enrolled
18-39 Years
NIAID
Trait
16-H-0132
CADASIL Disease Discovery
Completed Study; data analyses ongoing
18-100 Years
NHLBI
Index
15-I-0056
Collection of Plasma from Subjects that Recovered From or Were Vaccinated To Emerging Infectious Diseases
Enrolling by Invitation
18-70 Years
NIAID
Quantitative
15-AR-0060
The Role of PPAR-gamma Agonists in immunomodulation and Vascular Prevention in SLE (PPAR-SLE)
Completed Study; data analyses ongoing
18-99 Years
NIAMS
Index
14-AA-0181
NIAAA Natural History Protocol
Participants currently recruited/enrolled
18-100 Years
NIAAA
Trait
12-H-0110
An Open-label, Non-Randomized, Single-Arm Pilot Study to Evaluate the Effectiveness of Etidronate Treatment for Arterial Calcifications due to Deficiency in CD73 (ACDC)
Completed Study; data analyses ongoing
18-80 Years
NHLBI
Index
12-C-0160
Validation of the English Version of the Pain Interference Index and the Pain Rating Scale in Children, Adolescents, and Adults with Chronic Illness and their Parents
Completed Study; data analyses ongoing
18-125 Years
NCI
Index
09-C-0005
Randomized Trial of Cladribine (CdA) with Simultaneous or Delayed Rituximab to Eliminate Hairy Cell Leukemia Minimal Residual Disease
Participants currently recruited/enrolled
18-125 Years
NCI
Quantitative
08-DK-0004
High Sensitivity Screening of Compound Libraries to Discover a Drug for the Treatment of Sickle Cell Disease
Participants currently recruited/enrolled
18-100 Years
NIDDK
Trait
07-DK-0077
Study of the Phenotype of Overweight and Obese Adults
Participants currently recruited/enrolled
18-100 Years
NIDDK
Trait
06-M-0214
PET Measurement of Regional Rates of Cerebral Protein Synthesis in Subjects with Fragile X Syndrome
Completed Study; data analyses ongoing
18-24 Years
NIMH
Quantitative
04-CC-0119
Biomarkers and Protein Mass Expression Profiles in Bronchoalveolar Lavage from Patients with Lung Infiltrates
Participants currently recruited/enrolled
3-99 Years
CC
Mass
03-M-0211
Family Study of Affective and Anxiety Spectrum Disorders
Participants currently recruited/enrolled
7-120 Years
NIMH
Trait
01-H-0122
Collection and Storage of Umbilical Cord Hematopoietic Stem Cells for Sickle Cell Disease Therapy
Participants currently recruited/enrolled
18-45 Years
NHLBI
Trait
01-H-0088
Determining the Prevalence and Prognosis of Secondary Pulmonary Hypertension in Adult Patients with Sickle Cell Anemia
Completed Study; data analyses ongoing
18-125 Years
NHLBI
Trait
96-H-0100
Role of Genetic Factors in the Pathogenesis of Lung Disease
Participants currently recruited/enrolled
2-90 Years
NHLBI
Quantitative
94-E-0165
Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies
Participants currently recruited/enrolled
2-100 Years
NIEHS
Mass